What Is an IMPD?
Understanding the Investigational Medicinal Product Dossier
Regulatory approval is a pre-requisite prior to initiating any clinical trial that involves any medicinal products in the European Union. Among the most significant papers needed in this procedure is Investigational Medicinal Product Dossier (IMPD).
What Is a PADER? Understanding the Periodic Adverse Drug Experience Report
Pharmacovigilance plays a critical role in ensuring patient safety throughout a product’s lifecycle. One of the key regulatory requirements in the United States is the Periodic Adverse Drug Experience Report (PADER). This report allows regulatory authorities to continuously evaluate the safety profile of approved and marketed medicinal products.
What is GMP Inspection?
In the healthcare and pharmaceutical sectors, Good Manufacturing Practices (GMP) are the foundation of quality and safety of their products. A GMP inspection is a systematic exercise which is conducted by regulatory authorities like FDA ( United States Food and Drug Administration), EMA (European Medicines Agency) or WHO (World Health Organization).
Continent-Specific Global GMP and regulatory compliance Updates for API & Pharmaceutical Manufacturers
Introduction
Regulatory authorities worldwide are strengthening expectations around GMP robustness, quality maturity, contamination control, data integrity, and AI governance in pharmaceutical manufacturing. Global GMP and regulatory compliance updates across Africa, North America, Europe, Asia, and Oceania are increasingly aligned with ICH, PIC/S, WHO, and regional frameworks, emphasizing lifecycle control, digital governance, and inspection readiness.
What is an FDA Warning Letter?
An FDA Warning Letter is basically the FDA’s way of telling a company, “You broke the rules, and we noticed.” When the FDA spots a serious violation of federal laws or regulations, they send this letter straight to the company. It’s not just a head-up, it’s a demand for the company to fix the problem fast, or they’ll face bigger consequences.
